COMPARISON OF HEALTHCARE COSTS IN FRANCE OF COMBINATION NIVOLUMAB AND IPILIMUMAB TREATMENT VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA

被引：0
|
作者：
Bregman, B. [1 ]
Moshyk, A. [2 ]
Johnson, H. M. [3 ]
Potluri, R. [4 ]
Bhandari, H. [5 ]
Ranjan, S. [5 ]
机构：
[1] Bristol Myers Squibb, Rueil Malmaison 92, France
[2] Bristol Myers Squibb, Lawrenceville, NJ USA
[3] Bristol Myers Squibb, Uxbridge, Middx, England
[4] SmartAnalyst Inc, New York, NY USA
[5] SmartAnalyst India Pvt Ltd, Gurgaon, India
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN105
引用
收藏
页码：S441 / S441
页数：1
相关论文
共 50 条
  • [31] Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab
    Zaremba, A.
    Chorti, E.
    Jockenhoefer, F.
    Albrecht, M.
    Placke, J. M.
    Knispel, S.
    Schadendorf, D.
    Hadaschik, E.
    Roesch, A.
    Ugurel, S.
    Zimmer, L.
    Livingstone, E.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 38 - 38
  • [32] Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
    Carlino, Matteo S.
    Long, Georgina V.
    [J]. CLINICAL CANCER RESEARCH, 2016, 22 (16) : 3992 - 3998
  • [33] Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma (vol 373, pg 23, 2015)
    Chapman, Paul B.
    D'Angelo, Sandra P.
    Wolchok, Jedd D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (22): : 2185 - 2185
  • [34] A Randomized Phase II Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Patients with Advanced Gastrointestinal Stromal Tumors
    Singh, Arun S.
    Hecht, J. Randolph
    Rosen, Lee
    Wainberg, Zev A.
    Wang, Xiaoyan
    Douek, Michael
    Hagopian, Anahis
    Andes, Rachel
    Sauer, Lauren
    Brackert, Sandra R.
    Chow, Warren
    DeMatteo, Ronald
    Eilber, Fritz Christian
    Glaspy, John A.
    Chmielowski, Bartosz
    [J]. CLINICAL CANCER RESEARCH, 2022, 28 (01) : 84 - 94
  • [35] Milestones in the Treatment of malignant Melanoma Nivolumab in the Adjuvant and as a Combination Therapy with Ipilimumab in Patients with advanced Melanoma
    Sankawa, Yuri
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 (7-8) : 414 - 415
  • [36] Safety and Efficacy Implications of Discontinuing Combination Ipilimumab and Nivolumab in Advanced Melanoma
    Carlino, Matteo S.
    Sandhu, Shahneen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3792 - 3793
  • [37] PKPD relationship of ipilimumab plus nivolumab combination in patients with advanced melanoma
    Goldwirt, L.
    Louveau, B.
    Liv, T.
    Baroudjian, B.
    Allayous, C.
    Da Meda, L.
    Delyon, J.
    Sauvageon, H.
    Lebbe, C.
    Mourah, S.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 38 - 38
  • [38] Combination immune checkpoint blockade with ipilimumab and nivolumab in the management of advanced melanoma
    Spain, Lavinia
    Larkin, James
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (03) : 389 - 396
  • [39] The impact of BRAF mutation status on clinical outcomes with anti-PD-1 monotherapy versus combination ipilimumab/nivolumab in treatment-naive advanced stage melanoma
    Ma, Vincent T.
    Daignault-Newton, Stephanie
    Waninger, Jessica J.
    Journey, Sara
    Chopra, Zoey
    Tezel, Alangoya
    Redman, Bruce G.
    Fecher, Leslie A.
    Green, Michael D.
    Alva, Ajjai S.
    Lao, Christopher D.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2021, 34 (03) : 629 - 640
  • [40] Nivolumab (NIVO) monotherapy or in combination with ipilimumab (IPI) for treatment of recurrent small cell lung cancer (SCLC)
    Calvo, E.
    Lopez-Martin, J. A.
    Bendell, J.
    Eder, J. P.
    Taylor, M.
    Ott, P. A.
    Pietanza, M. C.
    Horn, L.
    Jaeger, D.
    De Braud, F.
    Morse, M. A.
    Ascierto, P. A.
    Le, D. T.
    Amin, A.
    Evans, J.
    Simon, J.
    Lin, C. S.
    Christensen, O.
    Antonia, S. J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S633 - S633
12345